178 related articles for article (PubMed ID: 1974471)
21. Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens.
Wang W; Li Y; Ali H; Zhao L; Mei D; Hu W; Jiang B
BMC Cancer; 2021 Dec; 21(1):1315. PubMed ID: 34879826
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).
Rodig SJ; Abramson JS; Pinkus GS; Treon SP; Dorfman DM; Dong HY; Shipp MA; Kutok JL
Clin Cancer Res; 2006 Dec; 12(23):7174-9. PubMed ID: 17145843
[TBL] [Abstract][Full Text] [Related]
23. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias.
Csanaky G; Matutes E; Vass JA; Morilla R; Catovsky D
Leukemia; 1997 Mar; 11(3):408-15. PubMed ID: 9067581
[TBL] [Abstract][Full Text] [Related]
24. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
25. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
[TBL] [Abstract][Full Text] [Related]
26. Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages.
Gros F; Sebti Y; de Guibert S; Branger B; Bernard M; Fauchet R; Amiot L
Neoplasia; 2006 Mar; 8(3):223-30. PubMed ID: 16611416
[TBL] [Abstract][Full Text] [Related]
27. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization.
Traweek ST; Liu J; Braziel RM; Johnson RM; Byrnes RK
Diagn Mol Pathol; 1995 Sep; 4(3):212-9. PubMed ID: 7493141
[TBL] [Abstract][Full Text] [Related]
28. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
Bühring HJ; Sures I; Jallal B; Weiss FU; Busch FW; Ludwig WD; Handgretinger R; Waller HD; Ullrich A
Blood; 1995 Sep; 86(5):1916-23. PubMed ID: 7544646
[TBL] [Abstract][Full Text] [Related]
29. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features.
Rimsza LM; Larson RS; Winter SS; Foucar K; Chong YY; Garner KW; Leith CP
Am J Clin Pathol; 2000 Jul; 114(1):66-75. PubMed ID: 10884801
[TBL] [Abstract][Full Text] [Related]
30. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
[TBL] [Abstract][Full Text] [Related]
31. Expression of adhesion molecules CD11/CD18 (Leu-CAMs, beta 2-integrins), CD54 (ICAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia.
Kimby E; Rincón J; Patarroyo M; Mellstedt H
Leuk Lymphoma; 1994 Apr; 13(3-4):297-306. PubMed ID: 7519509
[TBL] [Abstract][Full Text] [Related]
32. Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts.
De Waele M; Renmans W; Jochmans K; Schots R; Lacor P; Trullemans F; Otten J; Balduck N; Vander Gucht K; Van Camp B; Van Riet I
Eur J Haematol; 1999 Sep; 63(3):192-201. PubMed ID: 10485274
[TBL] [Abstract][Full Text] [Related]
33. Expression of adhesion molecules in childhood B-lineage-cell neoplasms.
Hara J; Matsuda Y; Fujisaki H; Tokimasa S; Ohta H; Osagi Y; Takai K
Int J Hematol; 2000 Jul; 72(1):69-73. PubMed ID: 10979212
[TBL] [Abstract][Full Text] [Related]
34. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
35. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
36. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
37. bcl-2 gene expression in hematopoietic cell differentiation.
Mariano MT; Moretti L; Donelli A; Grantini M; Montagnani G; Di Prisco AU; Torelli G; Torelli U; Narni F
Blood; 1992 Aug; 80(3):768-75. PubMed ID: 1638028
[TBL] [Abstract][Full Text] [Related]
38. Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia.
Reuss-Borst MA; Bühring HJ; Klein G; Müller CA
Ann Hematol; 1992 Oct; 65(4):169-74. PubMed ID: 1384721
[TBL] [Abstract][Full Text] [Related]
39. Modulation of adhesion molecule CD54 expression on CD34+ hematopoietic progenitors.
Arkin S; Ferrone S; Lipton JM
Exp Hematol; 1995 Jul; 23(7):588-96. PubMed ID: 7541368
[TBL] [Abstract][Full Text] [Related]
40. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
